A snapshot of the PD-1/PD-L1 pathway
Anti-PD-L1 mIgG1e3 monoclonal antibody | Atezolizumab-based
Mechanistic insight of predictive biomarkers for antitumor PD‑1/PD‑L1 blockade: A paradigm shift towards immunome evaluation (Review)
PDL1 e immunoterapici | L'immunologo risponde | alcase.eu
Frontiers | Regulation of PD-L1: Emerging Routes for Targeting Tumor Immune Evasion
The PD-1/PD-L1 pathway | Agilent
Frontiers | Noncanonical PD-1/PD-L1 Axis in Relation to the Efficacy of Anti-PD Therapy
Biomedicines | Free Full-Text | PD-1/PD-L1 Pathway: A Therapeutic Target in CD30+ Large Cell Lymphomas
Frontiers | PD-1/PD-L1 Based Combinational Cancer Therapy: Icing on the Cake
PD-1/L1 e anti-PD-1: test per il dosaggio della molecola e del farmaco – Listarfish.it – PRODOTTI PER RICERCA & DIAGNOSTICA
PD-1/PDL-1 immune checkpoint in tumorigenesis (Panel A). PD-1/PDL-1... | Download Scientific Diagram
Cells | Free Full-Text | The Importance of Exosomal PD-L1 in Cancer Progression and Its Potential as a Therapeutic Target
IJMS | Free Full-Text | Navigating through the PD-1/PDL-1 Landscape: A Systematic Review and Meta-Analysis of Clinical Outcomes in Hepatocellular Carcinoma and Their Influence on Immunotherapy and Tumor Microenvironment
The importance of exosomal PDL1 in tumour immune evasion | Nature Reviews Immunology
PD−L1 immunostaining: what pathologists need to know | Diagnostic Pathology | Full Text
Are PD-1 and PD-L1 Checkpoint Inhibitors As Good As We Thought?
Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway | Acta Pharmacologica Sinica
Cancer: anti-PD-1 / PD-L1 antibodies, new solutions for immunotherapy
PD-1/PD-L1 inhibitors treatment in lung cance | EurekAlert!
PD-1 & PD-L1 Inhibitors - Assay Genie
Frontiers | Adverse Effects of Anti-PD-1/PD-L1 Therapy in Non-small Cell Lung Cancer
The intracellular signalosome of PD-L1 in cancer cells | Signal Transduction and Targeted Therapy
PDL1 e immunoterapici | L'immunologo risponde | alcase.eu
